766 related articles for article (PubMed ID: 20102519)
21. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid.
Bigio EH; Wu JY; Deng HX; Bit-Ivan EN; Mao Q; Ganti R; Peterson M; Siddique N; Geula C; Siddique T; Mesulam M
Acta Neuropathol; 2013 Mar; 125(3):463-5. PubMed ID: 23378033
[No Abstract] [Full Text] [Related]
22. Clinical and pathological continuum of multisystem TDP-43 proteinopathies.
Geser F; Martinez-Lage M; Robinson J; Uryu K; Neumann M; Brandmeir NJ; Xie SX; Kwong LK; Elman L; McCluskey L; Clark CM; Malunda J; Miller BL; Zimmerman EA; Qian J; Van Deerlin V; Grossman M; Lee VM; Trojanowski JQ
Arch Neurol; 2009 Feb; 66(2):180-9. PubMed ID: 19204154
[TBL] [Abstract][Full Text] [Related]
23. ALS and FTLD: two faces of TDP-43 proteinopathy.
Liscic RM; Grinberg LT; Zidar J; Gitcho MA; Cairns NJ
Eur J Neurol; 2008 Aug; 15(8):772-80. PubMed ID: 18684309
[TBL] [Abstract][Full Text] [Related]
24. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
[TBL] [Abstract][Full Text] [Related]
25. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.
Kawakami I; Arai T; Hasegawa M
Acta Neuropathol; 2019 Nov; 138(5):751-770. PubMed ID: 31555895
[TBL] [Abstract][Full Text] [Related]
26. [Neuropathological similarities and differences between frontotemporal lobar degeneration with ubiquitin inclusions and amyotrophic lateral sclerosis with dementia].
Tan CF; Toyoshima Y; Kakita A; Takahashi H
Brain Nerve; 2009 Nov; 61(11):1319-27. PubMed ID: 19938689
[TBL] [Abstract][Full Text] [Related]
27. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.
Geser F; Martinez-Lage M; Kwong LK; Lee VM; Trojanowski JQ
J Neurol; 2009 Aug; 256(8):1205-14. PubMed ID: 19271105
[TBL] [Abstract][Full Text] [Related]
28. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.
Wils H; Kleinberger G; Janssens J; Pereson S; Joris G; Cuijt I; Smits V; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3858-63. PubMed ID: 20133711
[TBL] [Abstract][Full Text] [Related]
29. TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease.
Kwong LK; Neumann M; Sampathu DM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2007 Jul; 114(1):63-70. PubMed ID: 17492294
[TBL] [Abstract][Full Text] [Related]
30. Pathologic Involvement of Glutamatergic Striatal Inputs From the Cortices in TAR DNA-Binding Protein 43 kDa-Related Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis.
Riku Y; Watanabe H; Yoshida M; Mimuro M; Iwasaki Y; Masuda M; Ishigaki S; Katsuno M; Sobue G
J Neuropathol Exp Neurol; 2017 Sep; 76(9):759-768. PubMed ID: 28859339
[TBL] [Abstract][Full Text] [Related]
31. Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration.
Dutta K; Patel P; Rahimian R; Phaneuf D; Julien JP
Neurotherapeutics; 2017 Apr; 14(2):447-462. PubMed ID: 27928708
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43.
King A; Maekawa S; Bodi I; Troakes C; Al-Sarraj S
Neuropathology; 2011 Jun; 31(3):239-49. PubMed ID: 21118398
[TBL] [Abstract][Full Text] [Related]
33. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases.
Ishigaki S; Riku Y; Fujioka Y; Endo K; Iwade N; Kawai K; Ishibashi M; Yokoi S; Katsuno M; Watanabe H; Mori K; Akagi A; Yokota O; Terada S; Kawakami I; Suzuki N; Warita H; Aoki M; Yoshida M; Sobue G
Brain; 2020 Aug; 143(8):2398-2405. PubMed ID: 32770214
[TBL] [Abstract][Full Text] [Related]
34. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
35. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.
Kosaka T; Fu YJ; Shiga A; Ishidaira H; Tan CF; Tani T; Koike R; Onodera O; Nishizawa M; Kakita A; Takahashi H
Neuropathology; 2012 Aug; 32(4):373-84. PubMed ID: 22098653
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers for diseases with TDP-43 pathology.
Steinacker P; Barschke P; Otto M
Mol Cell Neurosci; 2019 Jun; 97():43-59. PubMed ID: 30399416
[TBL] [Abstract][Full Text] [Related]
37. An autopsy report of a familial amyotrophic lateral sclerosis case carrying VCP Arg487His mutation with a unique TDP-43 proteinopathy.
Matsubara T; Izumi Y; Oda M; Takahashi M; Maruyama H; Miyamoto R; Watanabe C; Tachiyama Y; Morino H; Kawakami H; Saito Y; Murayama S
Neuropathology; 2021 Apr; 41(2):118-126. PubMed ID: 33415820
[TBL] [Abstract][Full Text] [Related]
38. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
[TBL] [Abstract][Full Text] [Related]
39. TDP-43: a novel neurodegenerative proteinopathy.
Forman MS; Trojanowski JQ; Lee VM
Curr Opin Neurobiol; 2007 Oct; 17(5):548-55. PubMed ID: 17936612
[TBL] [Abstract][Full Text] [Related]
40. Towards a TDP-43-Based Biomarker for ALS and FTLD.
Feneberg E; Gray E; Ansorge O; Talbot K; Turner MR
Mol Neurobiol; 2018 Oct; 55(10):7789-7801. PubMed ID: 29460270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
